Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Shared mechanisms in perception and imagery of auditory accents

Vlek RJ, Schaefer RS, Gielen CC, Farquhar JD, Desain P.

Clin Neurophysiol. 2011 Aug;122(8):1526-32. doi: 10.1016/j.clinph.2011.01.042. Epub 2011 Feb 25.

Rapidly deteriorating parkinsonism and dysautonomia in patient with central pontine and extrapontine myelinolysis

Kwon DY, Seo WK, Park MH, Kang YS, Koh SB, Cha DR, Park KW.

Clin Neurol Neurosurg. 2011 Jul;113(6):513-4. doi: 10.1016/j.clineuro.2011.02.002. Epub 2011 Feb 26.

Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol

van Norden AG, de Laat KF, Gons RA, van Uden IW, van Dijk EJ, van Oudheusden LJ, Esselink RA, Bloem BR, van Engelen BG, Zwarts MJ, Tendolkar I, Olde-Rikkert MG, van der Vlugt MJ, Zwiers MP, Norris DG, de Leeuw FE.

BMC Neurol. 2011 Feb 28;11:29. doi: 10.1186/1471-2377-11-29.

GDNF and protection of adult central catecholaminergic neurons

Pascual A, Hidalgo-Figueroa M, Gómez-Díaz R, López-Barneo J.

J Mol Endocrinol. 2011 Jun 8;46(3):R83-92. doi: 10.1530/JME-10-0125. Print 2011 Jun.

The role of osteopontin in neurodegenerative diseases

Carecchio M, Comi C.

J Alzheimers Dis. 2011;25(2):179-85. doi: 10.3233/JAD-2011-102151.

ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-ioflupane SPET

Fernández-Corcuera P, Aguilar S, Viçens V, Mora J, Benitez A, García-Burillo A, Pomarol-Clotet E, McKenna P.

J Neural Transm (Vienna). 2011 Apr;118(4):647-50. doi: 10.1007/s00702-011-0615-8. Epub 2011 Feb 27.

Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel

Müller T, Jugel C, Ehret R, Ebersbach G, Bengel G, Muhlack S, Klostermann F.

J Neural Transm (Vienna). 2011 Sep;118(9):1329-33. doi: 10.1007/s00702-011-0614-9. Epub 2011 Feb 27.

Role of dysphagia in evaluating Parkinson patients for subthalamic nucleus stimulation: a case report

Allert N, Kelm D, Spottke A, Coenen VA.

J Neural Transm (Vienna). 2011 Sep;118(9):1345-8. doi: 10.1007/s00702-011-0608-7. Epub 2011 Feb 27.

Neuroprotection by spice-derived nutraceuticals: you are what you eat!

Kannappan R, Gupta SC, Kim JH, Reuter S, Aggarwal BB.

Mol Neurobiol. 2011 Oct;44(2):142-59. doi: 10.1007/s12035-011-8168-2. Epub 2011 Mar 1.

Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim

Weinreb O, Mandel S, Bar-Am O, Amit T.

J Neural Transm (Vienna). 2011 Mar;118(3):479-92. doi: 10.1007/s00702-011-0597-6. Epub 2011 Mar 1.

Hemiparkinsonism-hemiatrophy syndrome

Ayromlou H, Najmi S, Arami MA.

Arch Iran Med. 2011 Mar;14(2):152-4.

Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration

Wen Z, Yan Z, Hu K, Pang Z, Cheng X, Guo L, Zhang Q, Jiang X, Fang L, Lai R.

J Control Release. 2011 Apr 30;151(2):131-8. doi: 10.1016/j.jconrel.2011.02.022. Epub 2011 Feb 26.

Neurobehavioral mechanisms of temporal processing deficits in Parkinson's disease

Harrington DL, Castillo GN, Greenberg PA, Song DD, Lessig S, Lee RR, Rao SM.

PLoS One. 2011 Feb 25;6(2):e17461. doi: 10.1371/journal.pone.0017461.

Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach

Edwards YJ, Beecham GW, Scott WK, Khuri S, Bademci G, Tekin D, Martin ER, Jiang Z, Mash DC, ffrench-Mullen J, Pericak-Vance MA, Tsinoremas N, Vance JM.

PLoS One. 2011 Feb 22;6(2):e16917. doi: 10.1371/journal.pone.0016917.

Generic versus branded pharmacotherapy in Parkinson's disease: does it matter? A review

Go CL, Rosales RL, Schmidt P, Lyons KE, Pahwa R, Okun MS.

Parkinsonism Relat Disord. 2011 Jun;17(5):308-12. doi: 10.1016/j.parkreldis.2011.02.005. Epub 2011 Mar 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias